Skip to main content
. 2019 Feb 27;2019(1):hoz003. doi: 10.1093/hropen/hoz003

Table I.

Baseline characteristics by individualized AMH-based or standard dosing.

Type of dosing
Individualized Standard
N = 149 N = 72
Age (y), mean ± SD 32.2 ± 3.3 31.6 ± 3.2
Age groups, N (%) 29 (19.5) 21 (29.2)
 <30 74 (49.7) 37 (51.4)
 30–34
 35–38 46 (30.9) 14 (19.4)
BMI (kg/m2), mean ± SD 22.2 ± 4.1 22.0 ± 2.6
Duration of infertility (months), mean ± SD 27.3 ± 13.0 27.1 ± 10.3
Main cause of infertility, N (%)
 Male 75 (50.3) 45 (62.5)
 Tubal 14 (9.4) 4 (5.6)
 Combined factors 4 (2.7) 1 (1.4)
 Unexplained 56 (37.6) 22 (30.6)
Primary infertility, N (%) 103 (69.1) 54 (75.0)
Cycle length (d), mean ± SD 28.2 ± 1.8 28.1 ± 1.9
Ovarian volume (mL), mean ± SD 6.1 ± 2.6 6.2 ± 2.8
AFC, mean ± SD 20.3 ± 7.3 19.3 ± 7.5
AMH (pmol/L)*, median (IQR) 16.8 (12.0–23.0) 15.2 (10.6–23.5)
FSH (IU/L), median (IQR) 7.5 (6.2–8.9) 7.2 (6.1–8.4)
Treatment groups by AMH, N (%)
 AMH 4–11.9 33 (22.1) 20 (27.8)
 AMH 12–23.9 81 (55.4) 34 (47.2)
 AMH 24–40 35 (23.5) 18 (25.0)
Pretreatment stimulation characteristics by AMH stratum
 AMH 4–11.9 pmol/L
  AMH, median (IQR) 9.6 (6.6–10.7) 8.8 (6.6–9.6)
  FSH, median (IQR) 7.8 (6.5–9.2) 7.2 (6.8–8.6)
  AFC, mean ± SD 14.3 ± 4.8 12.9 ± 3.9
  AMH/AFC 0.64 ± 0.18 0.68 ± 0.27
 AMH 12–23.9 pmol/L
  AMH, median (IQR) 16.8 (13.6–20.0) 15.6 (13.0–20.0)
  FSH, median (IQR) 7.3 (6.2–9.0) 7.2 (6.2–8.8)
  AFC, mean ± SD 19.7 ± 5.4 19.7 ± 6.0
  AMH/AFC 0.93 ± 0.33 0.87 ± 0.20
 AMH 24–40 pmol/L
  AMH, median (IQR) 33 (28–35) 27 (24–29)
  FSH, median (IQR) 7.3 (6.6–8.0) 6.0 (5.6–7.9)
  AFC, mean ± SD 27.5 ± 7.3 25.8 ± 7.5
  AMH/AFC 1.22 ± 0.06 1.17 ± 0.4

AMH, anti-Müllerian hormone; AFC, antral follicle count. No statistical differences between groups using Student’s t-test, Mann–Whitney U test or Chi2-test as appropriate. *All serum AMH values in the present article are expressed as with the Elecsys assay.